A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

Autor:	Mead, G. M.1 Ben.Mead@suht.swest.nhs.uk, Cullen, M. H.2, Huddart, R.3, Harper, P.4, Rustin, G. J. S.5, Cook, P. A.6, Stenning, S. P.6, Mason, M.7, MRC Testicular Tumour Working Party (CORPORATE AUTHOR)
Zdroj:	British Journal of Cancer. 7/25/2005, Vol. 93 Issue 2, p178-184. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu